JP2018108937A5 - - Google Patents

Download PDF

Info

Publication number
JP2018108937A5
JP2018108937A5 JP2016221064A JP2016221064A JP2018108937A5 JP 2018108937 A5 JP2018108937 A5 JP 2018108937A5 JP 2016221064 A JP2016221064 A JP 2016221064A JP 2016221064 A JP2016221064 A JP 2016221064A JP 2018108937 A5 JP2018108937 A5 JP 2018108937A5
Authority
JP
Japan
Prior art keywords
optionally substituted
hydrogen
substituted alkyl
optionally
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016221064A
Other languages
English (en)
Japanese (ja)
Other versions
JP6978758B2 (ja
JP2018108937A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2016221064A priority Critical patent/JP6978758B2/ja
Priority claimed from JP2016221064A external-priority patent/JP6978758B2/ja
Priority to US15/809,845 priority patent/US10392400B2/en
Publication of JP2018108937A publication Critical patent/JP2018108937A/ja
Priority to US16/459,120 priority patent/US10844073B2/en
Publication of JP2018108937A5 publication Critical patent/JP2018108937A5/ja
Application granted granted Critical
Publication of JP6978758B2 publication Critical patent/JP6978758B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016221064A 2016-11-11 2016-11-11 パラジウム媒介ケトール化 Active JP6978758B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2016221064A JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化
US15/809,845 US10392400B2 (en) 2016-11-11 2017-11-10 Palladium-mediated ketolization
US16/459,120 US10844073B2 (en) 2016-11-11 2019-07-01 Palladium-mediated ketolization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016221064A JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化

Publications (3)

Publication Number Publication Date
JP2018108937A JP2018108937A (ja) 2018-07-12
JP2018108937A5 true JP2018108937A5 (https=) 2019-12-26
JP6978758B2 JP6978758B2 (ja) 2021-12-08

Family

ID=62240368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016221064A Active JP6978758B2 (ja) 2016-11-11 2016-11-11 パラジウム媒介ケトール化

Country Status (2)

Country Link
US (2) US10392400B2 (https=)
JP (1) JP6978758B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
SMT202200455T1 (it) 2017-04-05 2023-01-13 Harvard College Composto macrociclico e relativi usi
WO2019010363A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College HALICHONDRINES SYNTHESIS
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
WO2019099646A1 (en) 2017-11-15 2019-05-23 President And Fellows Of Harvard College Macrocyclic compounds and uses thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
US5352804A (en) 1993-01-19 1994-10-04 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 2
US5426194A (en) 1993-01-19 1995-06-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 1
JP4454151B2 (ja) 1998-06-17 2010-04-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 大環状類似体及びそれらの使用並びに調製方法
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
JP2001305734A (ja) * 2000-04-20 2001-11-02 Fuji Photo Film Co Ltd 光重合性組成物
JP2003261447A (ja) 2002-03-07 2003-09-16 Kyosei Seiyaku Kk 抗腫瘍剤
SI2522663T1 (sl) 2004-06-03 2015-08-31 Eisai R&D Management Co., Ltd. Vmesne spojine za pripravo halihondrina B
US20060154312A1 (en) 2004-12-09 2006-07-13 Sergei Agoulnik Tubulin isotype screening in cancer therapy using halichondrin B analogs
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
CN101657990B (zh) 2007-03-07 2014-03-19 交互数字技术公司 用于产生和处理MAC-ehs协议数据单元的方法和设备
US20100254996A1 (en) 2007-06-18 2010-10-07 Medimmune, Llc Synergistic treatment of cells that express epha2 and erbb2
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
CN101910180A (zh) 2007-11-16 2010-12-08 卫材R&D管理有限公司 用于软海绵素b类似物合成的新颖中间体和用于该中间体的新颖脱磺酰化反应
CA2720632C (en) 2008-04-04 2016-12-20 Eisai R&D Management Co., Ltd. Halichondrin b analogs
RU2579511C2 (ru) 2010-01-26 2016-04-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Производные фуро[3,2-в]пирана, применимые в синтезе аналогов
WO2012096926A2 (en) 2011-01-10 2012-07-19 President And Fellows Of Harvard College Method for delivering agents into cells using bacterial toxins
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
JP2015501818A (ja) 2011-12-16 2015-01-19 アルフォラ リサーチ インコーポレイテッドAlphora Research Inc. 3−((2s,5s)−4−メチレン−5−(3−オキソプロピル)テトラヒドロフラン−2−イル)プロパノール誘導体およびそれらの有用な中間体を調製する方法
CA2860446C (en) 2011-12-29 2017-01-10 Alphora Research Inc. 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation
US9278979B2 (en) 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
EP3016957A4 (en) 2013-07-03 2016-11-30 Alphora Res Inc SYNTHETIC METHOD FOR THE PRODUCTION OF CYCLIC C1-KETO ANALOGUE OF HALICHONDRIN B AND USEFUL INTERMEDIATE PRODUCTS, INCLUDING INTERMEDIATE PRODUCTS WITH -SO2- (P-TOLYL) GROUPS
BR112016009452B1 (pt) 2013-11-04 2022-06-07 Eisai R&D Management Co., Ltd Métodos de preparar intermediários na síntese de eribulina, métodos de preparar eribulina e mesilato de eribulina, e compostos intermediários
EP3077399B1 (en) 2013-12-06 2019-02-20 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin b analogs
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10208058B2 (en) 2014-09-09 2019-02-19 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
SMT202200455T1 (it) 2017-04-05 2023-01-13 Harvard College Composto macrociclico e relativi usi
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
WO2019010363A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College HALICHONDRINES SYNTHESIS

Similar Documents

Publication Publication Date Title
JP2018108937A5 (https=)
EA021854B1 (ru) Дисахариновая, дифумаровокислая, ди-1-гидрокси-2-нафтойнокислая и монобензойнокислая соли 4-(диметиламино)бутил-2-(4-((2-амино-4-метил-6-(пентиламино)пиримидин-5-ил)метил)фенил)ацетата
CN104402862B (zh) 艾立替尼的制备方法
WO2016012470A1 (en) New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
CA2722016A1 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
ES2594252T3 (es) Compuesto de quinolona y composición farmacéutica
RU2009110413A (ru) Способ получения производных 3-дигалогенметил-пиразол-4-карбоновой кислоты
KR102142797B1 (ko) 피리디닐아미노피리미딘 유도체의 메실레이트 염의 결정질 형태, 그의 제조 방법, 및 그의 용도
JP2010529986A5 (https=)
WO2009125841A1 (ja) 5-メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法
JPH06234741A (ja) 置換4−フエニルピリドン及び4−フエニル−2−アルコキシピリジン
WO2021231335A1 (en) Novel intermediates and synthesis for endochin-like quinolone compounds
WO2013018371A1 (ja) ビアリールエステル誘導体、及びそれを含む医薬
CN105418610A (zh) 一种10-羟基吴茱萸碱类抗肿瘤化合物及其制备方法和应用
CN101544670B (zh) 一种糖精阿德福韦酯及制备方法
JP2019523230A (ja) 抗転移性2H‐セレノフェノ[3,2‐h]クロメン、それらの合成、および同薬剤の使用方法
JP2008542359A5 (https=)
Le Anh et al. Synthesis and Molecular Structure of Dibenzo [4-(α-Thienyl-and α-Pyrrolyl) pyrido] aza-14-crown-4 Ethers
JP2020533308A5 (https=)
CN108794517B (zh) 一种精氨酸酶抑制剂及其制备方法与用途
Luo et al. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol
JP2010513510A5 (https=)
TWI439463B (zh) 青蒿素之二聚衍生物及其在抗癌治療之應用
Diwischek et al. Cerulenin analogues as inhibitors of efflux pumps in drug‐resistant Candida albicans
CN104829669A (zh) 具有细胞毒活性的2’,5’-双脱氧-5-氟尿嘧啶核苷衍生物、生产方法和应用